An Open-label, Randomized, Single Dose, Crossover Phase I Clinical Trial to Compare Pharmacokinetic Property of SYO-1126 and Glivec Film Coated Tab., 4T (400mg) in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 11 Jun 2012
At a glance
- Drugs Imatinib (Primary)
- Indications Haematological malignancies; Malignant melanoma; Myelodysplastic syndromes; Polycythaemia vera; Prostate cancer; Sarcoma
- Focus Pharmacokinetics
- 11 Jun 2012 Actual end date (April 2012) added as reported by ClinicalTrials.gov.
- 11 Jun 2012 Actual initiation date (Mar 2012) added as reported by ClinicalTrials.gov.
- 11 Jun 2012 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.